Various govt departments to work with ICMR to develop coronavirus vaccine

Image
ANI General News
Last Updated : Mar 31 2020 | 8:55 PM IST

The Council of Scientific and Industrial Research, Department of Science and Technology, and Department of Biotechnology will work with Indian Council of Medical Research (ICMR) to further the agenda of the development of a vaccine for coronavirus, said R Gangakhedkar, head, Epidemiology and Communicable Diseases Division of ICMR.

"CSIR, Department of Science and Technology, and Department of Biotechnology will work with the ICMR to further the agenda of the development of a vaccine for COVID-19," Gangakhedkar said at a press conference here on Tuesday.

Speaking on whether the country has the capacity to conduct tests for an increasing number of suspected coronavirus patients, he said, "Till now we have tested 42,788 samples, including 4,346 samples that were tested on March 30. It represents 36 per cent of our capacity.

"123 labs have been made functional, 49 private labs have been given permission. Yesterday 399 patients were tested in private labs," he added.

Meanwhile, Lav Aggarwal, Joint Secretary, Ministry of Health and Family Welfare, said that till now a total of 1,251 cases and 32 deaths have been reported in the country.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 31 2020 | 8:40 PM IST

Next Story